Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/09/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 58.5k | $13.20 | $771.7k | | 08/09/2023 |
05/22/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 25k | $21.86 | $545.8k | See footnote | 05/19/2023 |
05/19/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 800k | $2.29 | $1.8M | See footnote | 05/17/2023 |
05/19/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 50k | $22.55 | $1.1M | See footnote | 05/19/2023 |
05/18/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 150k | $2.16 | $323.9k | See footnote | 05/17/2023 |
05/18/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 30k | $21.76 | $652.7k | See footnote | 05/16/2023 |
05/17/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 30k | $21.30 | $639.4k | See footnote | 05/16/2023 |
05/17/2023 | STANDARD BIOTOOLS INC. | FLDM | Purchase | Common Stock | 250k | $1.89 | $471.6k | See footnote | 05/17/2023 |
05/16/2023 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 15k | $20.19 | $302.8k | See footnote | 05/16/2023 |
10/03/2022 | MAXCYTE, INC. | MXCT | Sale | Common Stock, par value $0.01 per share | 735.8k | $6.15 | $4.5M | | 10/03/2022 |
07/01/2022 | MAXCYTE, INC. | MXCT | Sale | Common Stock, par value $0.01 per share | 3.2M | $4.30 | $13.9M | | 07/01/2022 |
04/04/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Series B-1 Convertible Preferred Stock | 127.8k | $0.00 | $0 | | 04/04/2022 |
09/01/2021 | BIOLIFE SOLUTIONS INC | BLFS | Other (acquisition) | Common Stock, par value $.001 per share | 131.4k | $0.00 | $0 | | 09/01/2021 |
09/01/2021 | BIOLIFE SOLUTIONS INC | BLFS | Other (acquisition) | Common Stock, par value $.001 per share | 126.2k | $0.00 | $0 | | 09/01/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Conversion | Common Stock | 2.4M | $0.00 | $0 | See Footnotes | 08/03/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Purchase | Common Stock | 850k | $15.00 | $12.8M | See Footnotes | 08/03/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Conversion | Common Stock | 362k | $0.00 | $0 | See Footnotes | 08/03/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 2M | $0.00 | $0 | See Footnotes | 08/03/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 362k | $0.00 | $0 | See Footnotes | 08/03/2021 |
08/03/2021 | Tenaya Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 362k | $0.00 | $0 | See Footnotes | 08/03/2021 |
07/30/2021 | MAXCYTE, INC. | MXCT | Purchase | Common Stock, par value $0.01 per share | 1.8M | $13.00 | $23.4M | | 07/30/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 1M | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 310.3k | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Purchase | Common Stock | 1.1M | $19.00 | $20.9M | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A-2 Preferred Stock | 9.3M | $0.00 | $0 | | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 2.9M | $0.00 | $0 | | 06/21/2021 |
02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series D Preferred Stock | 2.9M | $0.00 | $0 | See footnote | 02/17/2021 |
02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 546.4k | $0.00 | $0 | See footnote | 02/17/2021 |
02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Purchase | Common Stock | 575k | $18.00 | $10.4M | See footnote | 02/17/2021 |
11/24/2020 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 1.6M | $22.50 | $36M | | 11/24/2020 |
07/02/2020 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 305.6k | $14.50 | $4.4M | | 07/01/2020 |
07/01/2020 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 685k | $14.50 | $9.9M | | 07/01/2020 |
05/22/2020 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 476.2k | $10.50 | $5M | | 05/22/2020 |
05/14/2020 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 1.9M | $10.50 | $20M | | 05/14/2020 |
11/20/2019 | BIOLIFE SOLUTIONS INC | BLFS | Purchase | Common Stock, par value $.001 per share | 20k | $15.68 | $313.6k | | 11/19/2019 |
|